Differential biological effects of scattered versus scanned clinical proton beams on Ewing sarcoma models
Abstract
BACKGROUND: Proton therapy (PT), first delivered passively using the Double Scattering (DS) technique, has shifted to active delivery through the Pencil Beam technique (PBS). However, the biological effectiveness of DS versus PBS proton beams on cancer cells, remain largely unknown. Given that PBS-PT is now commonly used to treat young patients with Ewing sarcoma, this point is of major importance in clinical practice and raises the question of the same effectiveness of both proton modalities on tumor control. METHODS: This study aims to compare the biological effects of clinical PBS vs. DS proton beams on various Ewing sarcoma cell lines. For this, we used a clinical Proteus 235 isochronous cyclotron capable of delivering both PBS and DS treatment modalities. Three different cancerous Ewing cell models were irradiated either in the plateau or in mid Spread-Out Bragg Peak (SOBP). We performed cell survival assays (2D monolayers and 3D spheroids), along with Reactive Oxygen Species (ROS) production (CellRox deep red assay) and quantification of 53BP1 foci 1 h and 18 h post-irradiation by immunofluorescence. RESULTS: No significant differences were observed in cell survival (either in 2D or in 3D) at the plateau or mid-SOBP between the two proton treatment modalities. However, higher ROS production and a greater number of residual 53BP1 foci were observed in PBS compared to DS technique. CONCLUSIONS: Both PBS and DS proton irradiation modalities exhibit the same in vitro biological effectiveness on Ewing sarcoma models. However, the question of the possible influence of the ROS/53BP1 increase on the onset of side effects or late toxicities when using the PBS irradiation technique, may arise.
Related
- Scattered data for the Scattered Islands: presence of the Yellow-bellied sea snake Hydrophis platura on Tromelin and first record for Juan de Nova, Western Indian Ocean Region
- Differential Neurodevelopmental Toxicity of Propofol and Fospropofol: Mechanistic Insights and Potential Clinical Implications-A Zebrafish Model Study.
- The role of platelet-rich plasma in repeated implantation failure: a review of biological mechanisms and clinical efficacy.
- Centrosomal protein 55: Research progress on biological characteristics, disease associations and clinical translational potential (Review)
- ExPert infers causal perturbations from cell states across biological and clinical contexts
BibTeX
@article{megninchanet2026differential,
title = {{Differential biological effects of scattered versus scanned clinical proton beams on Ewing sarcoma models}},
author = {Frédérique Mégnin-Chanet and Marc Laurans and Amelia Maia-Leite and Carine Laurent and Anthony Bonfrate and Karine Laud-Duval and Samia Chaouni and Annalisa Patriarca and Valentin Calugaru and Vincent Favaudon and Pierre Verrelle and Ludovic de Marzi},
journal = {Radiation Oncology},
year = {2026},
month = jul,
doi = {10.1186/s13014-026-02885-y},
url = {https://hal.science/hal-05750872v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Differential biological effects of scattered versus scanned clinical proton beams on Ewing sarcoma models
AU - Frédérique Mégnin-Chanet
AU - Marc Laurans
AU - Amelia Maia-Leite
AU - Carine Laurent
AU - Anthony Bonfrate
AU - Karine Laud-Duval
AU - Samia Chaouni
AU - Annalisa Patriarca
AU - Valentin Calugaru
AU - Vincent Favaudon
AU - Pierre Verrelle
AU - Ludovic de Marzi
PY - 2026
DA - 2026/07/06
JO - Radiation Oncology
DO - 10.1186/s13014-026-02885-y
UR - https://hal.science/hal-05750872v1
AB - BACKGROUND: Proton therapy (PT), first delivered passively using the Double Scattering (DS) technique, has shifted to active delivery through the Pencil Beam technique (PBS). However, the biological effectiveness of DS versus PBS proton beams on cancer cells, remain largely unknown. Given that PBS-PT is now commonly used to treat young patients with Ewing sarcoma, this point is of major importance in clinical practice and raises the question of the same effectiveness of both proton modalities on tumor control. METHODS: This study aims to compare the biological effects of clinical PBS vs. DS proton beams on various Ewing sarcoma cell lines. For this, we used a clinical Proteus 235 isochronous cyclotron capable of delivering both PBS and DS treatment modalities. Three different cancerous Ewing cell models were irradiated either in the plateau or in mid Spread-Out Bragg Peak (SOBP). We performed cell survival assays (2D monolayers and 3D spheroids), along with Reactive Oxygen Species (ROS) production (CellRox deep red assay) and quantification of 53BP1 foci 1 h and 18 h post-irradiation by immunofluorescence. RESULTS: No significant differences were observed in cell survival (either in 2D or in 3D) at the plateau or mid-SOBP between the two proton treatment modalities. However, higher ROS production and a greater number of residual 53BP1 foci were observed in PBS compared to DS technique. CONCLUSIONS: Both PBS and DS proton irradiation modalities exhibit the same in vitro biological effectiveness on Ewing sarcoma models. However, the question of the possible influence of the ROS/53BP1 increase on the onset of side effects or late toxicities when using the PBS irradiation technique, may arise.
SN - 1748-717X
ER -